IPG Investment Advisors LLC grew its holdings in shares of Nutrien Ltd. (NYSE:NTR - Free Report) by 170.0% during the 1st quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 82,725 shares of the company's stock after buying an additional 52,090 shares during the quarter. Nutrien makes up 0.9% of IPG Investment Advisors LLC's portfolio, making the stock its 29th largest position. IPG Investment Advisors LLC's holdings in Nutrien were worth $4,149,000 as of its most recent SEC filing.
Several other institutional investors and hedge funds have also recently added to or reduced their stakes in the business. Barclays PLC raised its holdings in shares of Nutrien by 192.7% in the 4th quarter. Barclays PLC now owns 411,056 shares of the company's stock valued at $18,395,000 after purchasing an additional 854,543 shares during the period. Deutsche Bank AG grew its stake in Nutrien by 11.3% in the 4th quarter. Deutsche Bank AG now owns 7,105,057 shares of the company's stock valued at $317,951,000 after buying an additional 721,935 shares during the last quarter. Geode Capital Management LLC grew its stake in Nutrien by 30.3% in the 4th quarter. Geode Capital Management LLC now owns 3,022,551 shares of the company's stock valued at $137,202,000 after buying an additional 702,948 shares during the last quarter. Bank of Nova Scotia grew its stake in Nutrien by 12.6% in the 4th quarter. Bank of Nova Scotia now owns 5,316,035 shares of the company's stock valued at $238,915,000 after buying an additional 595,994 shares during the last quarter. Finally, Allianz Asset Management GmbH grew its stake in Nutrien by 789.0% in the 1st quarter. Allianz Asset Management GmbH now owns 659,150 shares of the company's stock valued at $32,709,000 after buying an additional 585,002 shares during the last quarter. 63.10% of the stock is owned by institutional investors.
Analyst Ratings Changes
A number of brokerages recently commented on NTR. The Goldman Sachs Group upped their price target on shares of Nutrien from $53.00 to $59.00 and gave the company a "sell" rating in a research note on Friday, May 9th. Wells Fargo & Company increased their target price on shares of Nutrien from $59.00 to $62.00 and gave the stock an "equal weight" rating in a research report on Thursday, July 17th. Berenberg Bank increased their target price on shares of Nutrien from $54.00 to $59.00 and gave the stock a "buy" rating in a research report on Tuesday, April 15th. Barclays increased their target price on shares of Nutrien from $61.00 to $64.00 and gave the stock an "equal weight" rating in a research report on Monday, July 7th. Finally, Bank of America increased their target price on shares of Nutrien from $60.00 to $63.00 and gave the stock a "buy" rating in a research report on Wednesday, May 14th. One research analyst has rated the stock with a sell rating, nine have given a hold rating, seven have assigned a buy rating and one has given a strong buy rating to the stock. According to MarketBeat, the company has a consensus rating of "Hold" and a consensus price target of $63.33.
Check Out Our Latest Report on Nutrien
Nutrien Price Performance
NYSE:NTR traded down $0.01 on Friday, hitting $55.70. The company had a trading volume of 3,717,438 shares, compared to its average volume of 2,285,225. The stock has a market capitalization of $27.12 billion, a price-to-earnings ratio of 19.96, a PEG ratio of 1.06 and a beta of 0.81. The company has a current ratio of 1.22, a quick ratio of 0.59 and a debt-to-equity ratio of 0.41. The firm has a 50 day moving average of $59.98 and a two-hundred day moving average of $55.33. Nutrien Ltd. has a 52 week low of $43.69 and a 52 week high of $65.08.
Nutrien (NYSE:NTR - Get Free Report) last released its quarterly earnings results on Wednesday, August 6th. The company reported $2.65 earnings per share (EPS) for the quarter, beating the consensus estimate of $2.41 by $0.24. The firm had revenue of $10.30 billion during the quarter, compared to the consensus estimate of $10.40 billion. Nutrien had a net margin of 5.25% and a return on equity of 6.55%. The company's revenue for the quarter was up 2.8% on a year-over-year basis. During the same quarter last year, the firm earned $2.34 earnings per share. On average, research analysts anticipate that Nutrien Ltd. will post 3.72 earnings per share for the current year.
Nutrien Profile
(
Free Report)
Nutrien Ltd. provides crop inputs and services. The company operates through four segments: Retail, Potash, Nitrogen, and Phosphate. The Retail segment distributes crop nutrients, crop protection products, seeds, and merchandise products. The Potash segment provides granular and standard potash products.
Read More
Before you consider Nutrien, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Nutrien wasn't on the list.
While Nutrien currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
With the proliferation of data centers and electric vehicles, the electric grid will only get more strained. Download this report to learn how energy stocks can play a role in your portfolio as the global demand for energy continues to grow.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
